Annual Short Term Debt
$346.00 K
-$307.00 K-47.01%
31 December 2023
Summary:
Enlivex Therapeutics annual short term debt is currently $346.00 thousand, with the most recent change of -$307.00 thousand (-47.01%) on 31 December 2023. During the last 3 years, it has risen by +$143.00 thousand (+70.44%). ENLV annual short term debt is now -47.01% below its all-time high of $653.00 thousand, reached on 31 December 2022.ENLV Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$336.00 K
-$5000.00-1.47%
30 June 2024
Summary:
Enlivex Therapeutics quarterly short term debt is currently $336.00 thousand, with the most recent change of -$5000.00 (-1.47%) on 30 June 2024. Over the past year, it has dropped by -$365.00 thousand (-52.07%). ENLV quarterly short term debt is now -52.07% below its all-time high of $701.00 thousand, reached on 30 September 2023.ENLV Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.0% | -52.1% |
| 3 y3 years | +70.4% | -47.2% |
| 5 y5 years | +100.0% | - |
ENLV Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.0% | +70.4% | -52.1% | at low |
| 5 y | 5 years | -47.0% | -52.1% | +182.3% | |
| alltime | all time | -47.0% | -52.1% |
Enlivex Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $336.00 K(-1.5%) |
| Mar 2024 | - | $341.00 K(-1.4%) |
| Dec 2023 | $346.00 K(-47.0%) | $346.00 K(-50.6%) |
| Sept 2023 | - | $701.00 K(+5.1%) |
| June 2023 | - | $667.00 K(-2.2%) |
| Mar 2023 | - | $682.00 K(+4.4%) |
| Dec 2022 | $653.00 K(+5.8%) | $653.00 K(+0.6%) |
| Sept 2022 | - | $649.00 K(+3.2%) |
| June 2022 | - | $629.00 K(-9.4%) |
| Mar 2022 | - | $694.00 K(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $617.00 K(+203.9%) | $617.00 K(-3.0%) |
| Sept 2021 | - | $636.00 K(+202.9%) |
| June 2021 | - | $210.00 K(+2.4%) |
| Mar 2021 | - | $205.00 K(+1.0%) |
| Dec 2020 | $203.00 K(+65.0%) | $203.00 K(+10.9%) |
| Sept 2020 | - | $183.00 K(+48.8%) |
| June 2020 | - | $123.00 K(+3.4%) |
| Mar 2020 | - | $119.00 K(-3.3%) |
| Dec 2019 | $123.00 K(>+9900.0%) | $123.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Enlivex Therapeutics annual short term debt?
- What is the all time high annual short term debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual short term debt year-on-year change?
- What is Enlivex Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly short term debt year-on-year change?
What is Enlivex Therapeutics annual short term debt?
The current annual short term debt of ENLV is $346.00 K
What is the all time high annual short term debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual short term debt is $653.00 K
What is Enlivex Therapeutics annual short term debt year-on-year change?
Over the past year, ENLV annual short term debt has changed by -$307.00 K (-47.01%)
What is Enlivex Therapeutics quarterly short term debt?
The current quarterly short term debt of ENLV is $336.00 K
What is the all time high quarterly short term debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly short term debt is $701.00 K
What is Enlivex Therapeutics quarterly short term debt year-on-year change?
Over the past year, ENLV quarterly short term debt has changed by -$365.00 K (-52.07%)